| REVIEW ARTICLE |
|
| Year : 2011 | Volume
: 2
| Issue : 3 | Page : 153-155 |
|
|
Night-time exogenous melatonin administration may be a beneficial treatment for sleeping disorders in beta blocker patients
Auda Fares
Department of Internal Medicine, S. Johannes Hospital, Germany
Correspondence Address:
Auda Fares
Department of Internal Medicine, Albert-Schlangen Str. 36 50181, Bedburg
Germany
 PMID: 22022142
|
|
|
Sleep disorders are the common side effects of beta blockers. Beta blockers have been shown to reduce the production of melatonin via specific inhibition of adrenergic beta1-receptors. Exogenous melatonin, taken in the evening as a supplement, could reduce the central nervous system (CNS) side effects (sleep disorder) associated with beta-adrenergic receptor blockers as well as the potential risk associated with reduction of the melatonin synthesis. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
